C38 UNDERSTANDING THERAPEUTICS IN IPF: Patients With Idiopathic Pulmonary Fibrosis And Forced Vital Capacity < 50% Predicted: Is There A Role For Antifibrotic Therapy?

Corresponding author's email: jonathan.galli2@tuhs.temple.edu Rationale: The clinical efficacy of antifibrotic agents in idiopathic pulmonary fibrosis (IPF) patients with forced vital capacity (FVC) < 50% predicted is not known. Data was collected regarding baseline demographics, supplemental oxygen requirements, spirometry, DLco, six-minute walk distance (6MWD), IPF exacerbations, hospitalizations for respiratory failure, and mortality.